PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $486,000 | +31.0% | 46,600 | +5.9% | 0.00% | 0.0% |
| Q1 2020 | $371,000 | +22.0% | 44,000 | +26.8% | 0.00% | – |
| Q4 2019 | $304,000 | +21.6% | 34,700 | +49.6% | 0.00% | – |
| Q3 2019 | $250,000 | -20.6% | 23,200 | -6.5% | 0.00% | – |
| Q2 2019 | $315,000 | -79.0% | 24,800 | -35.9% | 0.00% | -100.0% |
| Q1 2019 | $1,501,000 | -54.5% | 38,700 | +16.0% | 0.00% | -60.0% |
| Q4 2017 | $3,298,000 | -75.4% | 33,362 | -70.2% | 0.01% | -75.0% |
| Q3 2017 | $13,409,000 | +90.6% | 111,979 | +39.1% | 0.02% | +81.8% |
| Q2 2017 | $7,036,000 | +470.2% | 80,498 | +142.7% | 0.01% | +450.0% |
| Q1 2017 | $1,234,000 | +93.4% | 33,169 | +59.7% | 0.00% | +100.0% |
| Q4 2016 | $638,000 | -62.8% | 20,771 | -18.8% | 0.00% | -66.7% |
| Q3 2016 | $1,715,000 | +107.4% | 25,571 | -7.9% | 0.00% | +50.0% |
| Q2 2016 | $827,000 | -39.7% | 27,771 | -40.5% | 0.00% | -33.3% |
| Q1 2016 | $1,372,000 | -63.6% | 46,700 | -2.9% | 0.00% | -57.1% |
| Q4 2015 | $3,771,000 | -1.5% | 48,100 | -5.3% | 0.01% | -12.5% |
| Q3 2015 | $3,828,000 | -43.1% | 50,800 | -11.8% | 0.01% | -33.3% |
| Q2 2015 | $6,725,000 | -61.1% | 57,600 | -21.4% | 0.01% | -61.3% |
| Q1 2015 | $17,307,000 | +55.5% | 73,300 | +24.7% | 0.03% | +63.2% |
| Q4 2014 | $11,129,000 | -33.4% | 58,800 | -16.0% | 0.02% | -34.5% |
| Q3 2014 | $16,700,000 | +294.7% | 70,000 | +9.2% | 0.03% | +314.3% |
| Q2 2014 | $4,231,000 | -34.5% | 64,100 | +3.4% | 0.01% | -41.7% |
| Q1 2014 | $6,457,000 | +7.3% | 62,000 | +6.7% | 0.01% | +9.1% |
| Q4 2013 | $6,015,000 | +199.0% | 58,100 | +54.9% | 0.01% | +175.0% |
| Q3 2013 | $2,012,000 | +27.3% | 37,500 | +5.3% | 0.00% | +33.3% |
| Q2 2013 | $1,580,000 | – | 35,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |